9/4/2025, 2:44:04 pm

IPO Watch: Anthem Biosciences gets SEBI nod to launch ₹3,395 crore IPO

Anthem Biosciences Limited has received SEBI approval for its IPO, which involves an offer for sale of up to ₹3,395 crore by promoters, investors, and shareholders. The Bengaluru-based firm reported a 34.3% revenue increase to ₹1,419 crore in FY24, with a profit of ₹367 crore. It provides CRDMO services and produces specialty ingredients and APIs.